269 related articles for article (PubMed ID: 22654442)
1. Serrated polyposis syndrome: molecular, pathological and clinical aspects.
Guarinos C; Sánchez-Fortún C; Rodríguez-Soler M; Alenda C; Payá A; Jover R
World J Gastroenterol; 2012 May; 18(20):2452-61. PubMed ID: 22654442
[TBL] [Abstract][Full Text] [Related]
2. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum.
Kambara T; Simms LA; Whitehall VL; Spring KJ; Wynter CV; Walsh MD; Barker MA; Arnold S; McGivern A; Matsubara N; Tanaka N; Higuchi T; Young J; Jass JR; Leggett BA
Gut; 2004 Aug; 53(8):1137-44. PubMed ID: 15247181
[TBL] [Abstract][Full Text] [Related]
3. Serrated pathway in colorectal carcinogenesis.
Yamane L; Scapulatempo-Neto C; Reis RM; Guimarães DP
World J Gastroenterol; 2014 Mar; 20(10):2634-40. PubMed ID: 24627599
[TBL] [Abstract][Full Text] [Related]
4. The case for a genetic predisposition to serrated neoplasia in the colorectum: hypothesis and review of the literature.
Young J; Jass JR
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1778-84. PubMed ID: 17035382
[TBL] [Abstract][Full Text] [Related]
5. BRAF and KRAS Mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status.
Yang S; Farraye FA; Mack C; Posnik O; O'Brien MJ
Am J Surg Pathol; 2004 Nov; 28(11):1452-9. PubMed ID: 15489648
[TBL] [Abstract][Full Text] [Related]
6. The serrated neoplasia pathway of colorectal tumors: Identification of MUC5AC hypomethylation as an early marker of polyps with malignant potential.
Renaud F; Mariette C; Vincent A; Wacrenier A; Maunoury V; Leclerc J; Coppin L; Crépin M; Van Seuningen I; Leteurtre E; Buisine MP
Int J Cancer; 2016 Mar; 138(6):1472-81. PubMed ID: 26476272
[TBL] [Abstract][Full Text] [Related]
7. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points.
O'Brien MJ; Yang S; Mack C; Xu H; Huang CS; Mulcahy E; Amorosino M; Farraye FA
Am J Surg Pathol; 2006 Dec; 30(12):1491-501. PubMed ID: 17122504
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis and management of serrated polyps: current status and future directions.
Anderson JC
Gut Liver; 2014 Nov; 8(6):582-9. PubMed ID: 25368744
[TBL] [Abstract][Full Text] [Related]
9. [Research progress of serrated polyposis syndrome].
Dong S; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Oct; 19(10):1197-1200. PubMed ID: 27781259
[TBL] [Abstract][Full Text] [Related]
10. RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation.
Yan HHN; Lai JCW; Ho SL; Leung WK; Law WL; Lee JFY; Chan AKW; Tsui WY; Chan ASY; Lee BCH; Yue SSK; Man AHY; Clevers H; Yuen ST; Leung SY
Gut; 2017 Sep; 66(9):1645-1656. PubMed ID: 27329244
[TBL] [Abstract][Full Text] [Related]
11. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
Kim JH; Bae JM; Cho NY; Kang GH
Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
[TBL] [Abstract][Full Text] [Related]
12. A serrated colorectal cancer pathway predominates over the classic WNT pathway in patients with hyperplastic polyposis syndrome.
Boparai KS; Dekker E; Polak MM; Musler AR; van Eeden S; van Noesel CJ
Am J Pathol; 2011 Jun; 178(6):2700-7. PubMed ID: 21641392
[TBL] [Abstract][Full Text] [Related]
13. Colorectal carcinoma occurring via the adenoma-carcinoma pathway in patients with serrated polyposis syndrome.
Nakamura F; Sato Y; Okamoto K; Fujino Y; Mitsui Y; Kagemoto K; Kawaguchi T; Miyamoto H; Muguruma N; Sonoda T; Tsuneyama K; Takayama T
J Gastroenterol; 2022 Apr; 57(4):286-299. PubMed ID: 35194694
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological characteristics of serrated polyps as precursors to colorectal cancer: Current status and management.
Okamoto K; Kitamura S; Kimura T; Nakagawa T; Sogabe M; Miyamoto H; Muguruma N; Takayama T
J Gastroenterol Hepatol; 2017 Feb; 32(2):358-367. PubMed ID: 27376251
[TBL] [Abstract][Full Text] [Related]
15. Distinct CpG island methylation profiles and BRAF mutation status in serrated and adenomatous colorectal polyps.
Kim YH; Kakar S; Cun L; Deng G; Kim YS
Int J Cancer; 2008 Dec; 123(11):2587-93. PubMed ID: 18798261
[TBL] [Abstract][Full Text] [Related]
16. Molecular classification and genetic pathways in hyperplastic polyposis syndrome.
Carvajal-Carmona LG; Howarth KM; Lockett M; Polanco-Echeverry GM; Volikos E; Gorman M; Barclay E; Martin L; Jones AM; Saunders B; Guenther T; Donaldson A; Paterson J; Frayling I; Novelli MR; Phillips R; Thomas HJ; Silver A; Atkin W; Tomlinson IP
J Pathol; 2007 Aug; 212(4):378-85. PubMed ID: 17503413
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-31 expression in relation to BRAF mutation, CpG island methylation and colorectal continuum in serrated lesions.
Ito M; Mitsuhashi K; Igarashi H; Nosho K; Naito T; Yoshii S; Takahashi H; Fujita M; Sukawa Y; Yamamoto E; Takahashi T; Adachi Y; Nojima M; Sasaki Y; Tokino T; Baba Y; Maruyama R; Suzuki H; Imai K; Yamamoto H; Shinomura Y
Int J Cancer; 2014 Dec; 135(11):2507-15. PubMed ID: 24752710
[TBL] [Abstract][Full Text] [Related]
18. Serrated Colorectal Lesions: An Up-to-Date Review from Histological Pattern to Molecular Pathogenesis.
Mezzapesa M; Losurdo G; Celiberto F; Rizzi S; d'Amati A; Piscitelli D; Ierardi E; Di Leo A
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457279
[TBL] [Abstract][Full Text] [Related]
19. Colorectal serrated adenocarcinoma.
Mäkinen MJ
Histopathology; 2007 Jan; 50(1):131-50. PubMed ID: 17204027
[TBL] [Abstract][Full Text] [Related]
20. BRAF mutations in aberrant crypt foci and hyperplastic polyposis.
Beach R; Chan AO; Wu TT; White JA; Morris JS; Lunagomez S; Broaddus RR; Issa JP; Hamilton SR; Rashid A
Am J Pathol; 2005 Apr; 166(4):1069-75. PubMed ID: 15793287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
